Clinical Trial Update: Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the addition of benralizumab to high-dose inhaled corticosteroids with a LABA in uncontrolled asthma has completed, with efficacy and s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2017-05-03